drug · Product Intelligence

Liraglutide
Pipeline Intelligence

Liraglutide: 3 indexed trials, 3 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
3Indexed trials
▦
3Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT01843075Imperial College London · alzheimersPHASE2
NCT02953665Cedars-Sinai Medical Center · parkinsonsPHASE2
NCT05313529The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · dementia_otherNA

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.